Sector: PHARMA & CHEMICALS

AGM Date: 2025-12-15

P/E: 7.37

Year End: 30 June

Share Distribution: See Details

Category: A

Bonus: 5%-2020,7%-2019,7%-2018,7.5%-2017, 10%-2016, 12.50%-2015, 15%-2014, 30%-2013, 40%-2012, 35%-2011, 30%-2010, 25%-2009, 35%-2008, 50%-2007, 20%-2006, 15%-2005, 20%-2004

Authorized Capital: 10000 (Mn)

No. of Share: 886451010

SQURPHARMA: Credit Rating Information and Services PLC (CRISL) has assigned the rating of the Company as ''AAA'' in the long term and ''ST-1'' in the short term along with Stable outlook in consideration of its audited financials up to June 30, 2025; unaudited financials up to September 30, 2025 and other relevant quantitative as well as qualitative information up to the date of rating declaration.